Buckingham Capital Management Holding in H And E Equipment Services I (HEES) Trimmed as Shares Declined; Compton Capital Management Cut Gilead Sciences (GILD) Position by $302,535

February 15, 2018 - By Stephen Andrade

Compton Capital Management Inc decreased its stake in Gilead Sciences Inc (GILD) by 5.65% based on its latest 2017Q3 regulatory filing with the SEC. Compton Capital Management Inc sold 3,735 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 62,360 shares of the health care company at the end of 2017Q3, valued at $5.05M, down from 66,095 at the end of the previous reported quarter. Compton Capital Management Inc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $107.10 billion market cap company. The stock increased 0.20% or $0.1658 during the last trading session, reaching $81.9858. About 3.83M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 15, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

David Keidan decreased its stake in H And E Equipment Services I (HEES) by 33.17% based on its latest 2017Q3 regulatory filing with the SEC. Buckingham Capital Management Inc sold 160,316 shares as the company’s stock declined 21.91% while stock markets rallied. The hedge fund run by David Keidan held 322,973 shares of the company at the end of 2017Q3, valued at $9.43M, down from 483,289 at the end of the previous reported quarter. Buckingham Capital Management Inc who had been investing in H And E Equipment Services I for a number of months, seems to be less bullish one the $1.27B market cap company. The stock decreased 1.27% or $0.46 during the last trading session, reaching $35.71. About 120,539 shares traded. H&E Equipment Services, Inc. (NASDAQ:HEES) has risen 3.15% since February 15, 2017 and is uptrending. It has underperformed by 13.55% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Mkt Perform” rating given on Tuesday, September 27 by Leerink Swann. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Friday, October 27 by Jefferies. As per Wednesday, February 7, the company rating was maintained by BMO Capital Markets. BMO Capital Markets maintained the shares of GILD in report on Monday, August 28 with “Hold” rating. Bank of America maintained the shares of GILD in report on Wednesday, February 7 with “Neutral” rating. The firm earned “Buy” rating on Sunday, October 29 by Mizuho. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Thursday, September 28 by Mizuho. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Thursday, September 22 by Berenberg. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Jefferies on Friday, January 26. Mizuho maintained the shares of GILD in report on Wednesday, November 8 with “Buy” rating.

Since August 30, 2017, it had 0 insider buys, and 13 insider sales for $51.09 million activity. Another trade for 50,000 shares valued at $4.18 million was made by MARTIN JOHN C on Thursday, February 1. Washington Robin L sold 51,820 shares worth $4.40M. Meyers James R also sold $4.99 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, August 31.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It improved, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Parkwood Ltd Company invested in 16,469 shares. Cape Cod Five Cents Retail Bank invested in 0.04% or 3,125 shares. The California-based Capital Intll Ltd Ca has invested 0.62% in Gilead Sciences, Inc. (NASDAQ:GILD). Guggenheim Cap Ltd Liability Co owns 0.28% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 1.50 million shares. Morgan Stanley, a New York-based fund reported 8.97 million shares. Salem Inv Counselors holds 92,897 shares. Private reported 12,457 shares. Clean Yield Grp Inc invested 1.58% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Cornerstone Cap Incorporated owns 0.73% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 51,236 shares. Tdam Usa Inc reported 31,923 shares or 0.15% of all its holdings. Nordea Investment invested 0.23% in Gilead Sciences, Inc. (NASDAQ:GILD). Needelman Asset reported 15,490 shares. Transamerica Fincl Advsr Inc stated it has 0% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Vision Cap Mgmt has 1.5% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 58,135 shares. Clark Estates Inc accumulated 48,050 shares or 0.65% of the stock.

Analysts await H&E Equipment Services, Inc. (NASDAQ:HEES) to report earnings on February, 22. They expect $0.42 earnings per share, up 20.00% or $0.07 from last year’s $0.35 per share. HEES’s profit will be $14.97M for 21.26 P/E if the $0.42 EPS becomes a reality. After $0.76 actual earnings per share reported by H&E Equipment Services, Inc. for the previous quarter, Wall Street now forecasts -44.74% negative EPS growth.

Among 6 analysts covering H&E Equipment Services (NASDAQ:HEES), 4 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive. H&E Equipment Services had 15 analyst reports since July 31, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained the shares of HEES in report on Tuesday, September 12 with “Hold” rating. The rating was maintained by RBC Capital Markets on Monday, June 5 with “Buy”. The rating was maintained by RBC Capital Markets on Thursday, July 27 with “Buy”. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with “Buy”. As per Thursday, January 11, the company rating was maintained by RBC Capital Markets. As per Friday, January 15, the company rating was upgraded by Longbow. Longbow upgraded the stock to “Buy” rating in Monday, January 18 report. The rating was maintained by UBS on Friday, October 27 with “Sell”. The rating was initiated by Bank of America on Tuesday, September 26 with “Buy”. RBC Capital Markets maintained the shares of HEES in report on Tuesday, September 12 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts